What You Need to Know About the EU’s New Data Protection Law

13/09/2017 - 13 minutes

The EU’s new data protection law is going to have a great impact on companies worldwide, including those involved in clinical trials. Here’s what you have to know and how to act!

In May 2018, the European Union’s new data protection law, the General Data Protection Regulation (GDPR), is set to replace the current Data Protection Directive (DPD). Although this just sounds like a bunch of complicated words, it will actually have a wide-reaching effect on companies worldwide.

You may read this and wonder why you should care. Well, if your company handles personal data of any sort, then you will likely be affected. One of the sectors hit especially hard by the new changes to the data protection law is the drug development industry. Namely, anyone who is involved in a clinical trial, from sponsors and investigators to CROs and vendors.

Starting in Spring next year,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

Support Us

Become a Member